Personalis (PSNL)
Whole-genome liquid biopsy tests that track cancer recurrence at the molecular level.
$16.36
After-hours close+0.01 (+0.06%)
At close$16.35(+0.68%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.26
Revenue estimate
$21.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.23−$0.18−$0.23−$0.24−$0.26−$0.29−$0.30Pending
Estimate−$0.32−$0.23−$0.25−$0.28−$0.31−$0.23−$0.26−$0.26
Surprise+28.1%+21.7%+8.0%+14.3%+16.1%−26.1%−13.9%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$16.8M$20.6M$17.2M$14.5M$17.3M$15.5M$22.4MPending
Estimate$15.5M$17.4M$20.1M$17.0M$17.0M$14.5M$16.7M$21.5M
Surprise+8.6%+18.3%−14.5%−14.9%+1.7%+6.8%+34.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.20 | — | — |
| Sep 2028 | −$0.20 | — | — |
| Jun 2028 | −$0.16 | — | — |
| Mar 2028 | −$0.15 | — | — |
| Dec 2027 | −$0.19 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.24 | — | — |
| Mar 2027 | −$0.24 | — | — |
| Dec 2026 | −$0.25 | — | — |
| Nov 2026 | −$0.26 | — | — |
| Aug 2026 | −$0.26 | −$0.30 | −13.9% |
| May 2026 | −$0.23 | −$0.29 | −26.1% |
| Feb 2026 | −$0.31 | −$0.26 | +16.1% |
| Nov 2025 | −$0.28 | −$0.24 | +14.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Mar 2019 | |||
| Jun 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.20 | — | — | $43.0M | — | — | — |
| Sep 2028 | −$0.20 | — | — | $38.6M | — | — | — |
| Jun 2028 | −$0.16 | — | — | $32.0M | — | — | — |
| Mar 2028 | −$0.15 | — | — | $28.1M | — | — | — |
| Dec 2027 | −$0.19 | — | — | $32.6M | — | — | — |
| Sep 2027 | −$0.19 | — | — | $29.4M | — | — | — |
| Jun 2027 | −$0.24 | — | — | $24.3M | — | — | — |
| Mar 2027 | −$0.24 | — | — | $23.5M | — | — | — |
| Dec 2026 | −$0.25 | — | — | $25.0M | — | — | — |
| Nov 3, 2026 | −$0.26 | — | — | $21.5M | — | — | — |
| Aug 4, 2026 | −$0.26 | −$0.30 | −13.9% | $16.7M | $22.4M | +34.0% | 0.0% |
| May 7, 2026 | −$0.23 | −$0.29 | −26.1% | $14.5M | $15.5M | +6.8% | −0.2% |
| Feb 26, 2026 | −$0.31 | −$0.26 | +16.1% | $17.0M | $17.3M | +1.7% | +0.3% |
| Nov 4, 2025 | −$0.28 | −$0.24 | +14.3% | $17.0M | $14.5M | −14.9% | −12.3% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 25, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 13, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Jun 20, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |